ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 232 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2021. The put-call ratio across all filers is 8.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $717 | +73.6% | 23,366 | +161.2% | 0.00% | 0.0% |
| Q2 2023 | $413 | +15.0% | 8,946 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $359 | -13.3% | 8,946 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $414 | -99.9% | 8,946 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $370,000 | -96.0% | 8,946 | -94.2% | 0.00% | -96.0% |
| Q2 2022 | $9,171,000 | -17.8% | 153,716 | 0.0% | 0.05% | -2.0% |
| Q1 2022 | $11,163,000 | -13.6% | 153,716 | 0.0% | 0.05% | -3.8% |
| Q4 2021 | $12,926,000 | -6.8% | 153,716 | 0.0% | 0.05% | -13.1% |
| Q3 2021 | $13,864,000 | +14.4% | 153,716 | +20.9% | 0.06% | +15.1% |
| Q2 2021 | $12,124,000 | -16.3% | 127,153 | 0.0% | 0.05% | -22.1% |
| Q1 2021 | $14,478,000 | -17.8% | 127,153 | -0.1% | 0.07% | -20.0% |
| Q4 2020 | $17,621,000 | +2297.4% | 127,290 | +1322.9% | 0.08% | +2025.0% |
| Q3 2020 | $735,000 | +5.0% | 8,946 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $700,000 | +76.3% | 8,946 | 0.0% | 0.00% | +33.3% |
| Q1 2020 | $397,000 | +37.4% | 8,946 | +32.1% | 0.00% | +50.0% |
| Q4 2019 | $289,000 | -0.3% | 6,773 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $290,000 | -32.6% | 6,773 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $430,000 | -8.5% | 6,773 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $470,000 | +59.9% | 6,773 | 0.0% | 0.00% | +50.0% |
| Q4 2018 | $294,000 | -43.1% | 6,773 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $517,000 | -0.8% | 6,773 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $521,000 | +51.0% | 6,773 | 0.0% | 0.00% | +50.0% |
| Q1 2018 | $345,000 | +9.9% | 6,773 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $314,000 | -13.0% | 6,773 | 0.0% | 0.00% | -33.3% |
| Q3 2017 | $361,000 | -14.3% | 6,773 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $421,000 | -8.3% | 6,773 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $459,000 | -3.6% | 6,773 | 0.0% | 0.00% | -25.0% |
| Q4 2016 | $476,000 | -0.8% | 6,773 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $480,000 | +45.0% | 6,773 | 0.0% | 0.00% | +33.3% |
| Q2 2016 | $331,000 | -22.8% | 6,773 | 0.0% | 0.00% | -25.0% |
| Q1 2016 | $429,000 | -21.1% | 6,773 | +39.6% | 0.00% | -20.0% |
| Q4 2015 | $544,000 | +110.9% | 4,850 | +80.9% | 0.01% | +150.0% |
| Q3 2015 | $258,000 | -6.2% | 2,681 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $275,000 | – | 2,681 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 437,512 | $31,772,000 | 2.80% |
| RTW INVESTMENTS, LP | 1,373,284 | $99,728,000 | 2.06% |
| Rock Springs Capital Management LP | 1,028,109 | $74,661,000 | 1.88% |
| Privium Fund Management B.V. | 112,727 | $8,186,000 | 1.81% |
| Avidity Partners Management LP | 869,000 | $63,107,000 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 525,100 | $38,133,000 | 1.16% |
| Boxer Capital, LLC | 200,000 | $14,524,000 | 0.75% |
| SECTOR GAMMA AS | 46,221 | $3,357,000 | 0.73% |
| FEDERATED HERMES, INC. | 3,987,728 | $289,589,000 | 0.65% |
| EMERALD ADVISERS, LLC | 223,952 | $16,263,000 | 0.62% |